Psilocybin therapy for chronic cancer pain
Part of Cancer, Mental health, Pain clinical trials.
This trial tests if a single dose of psilocybin (a psychedelic drug from certain mushrooms) given with psychological support can help reduce long-term pain in people with cancer who are already taking opioid painkillers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old and have active cancer at any stage.
- You have had moderate to severe pain from cancer or its treatment for at least 3 months.
- You are currently taking opioid pain medicine and have been on a stable dose for at least one month.
- You are able to read, write, and speak English and can swallow pills.
- You agree to stop using cannabis for about 7-8 weeks and avoid alcohol and other non-prescribed psychoactive drugs around dosing sessions.
- You must have a caregiver or family member who can drive you home after the treatment session.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.
This trial tests whether psilocybin (a psychedelic medication) can help people who have both chronic nerve pain and depression that hasn't responded to standard treatments. The goal is to see if it can reduce pain and improve mood.
This trial tests whether psilocybin (a psychedelic drug) can help with severe cancer pain. You may qualify if your pain is high despite strong medications and you are willing to be monitored closely.
This trial tests if psilocybin-assisted therapy can help reduce the intense worry that cancer might come back. It is for people who have finished their main treatments for early-stage breast cancer or advanced ovarian cancer.
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.
Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.